Open the mobile version, with barcode scanning
Class III Terminated

Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC Only. GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108.

Why: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Company
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Aiken, SC, United States
Reported
Apr 30, 2014
Recall started
Feb 20, 2014
Ended
Jan 20, 2017
Where sold
U.S. Nationwide
Amount
150 cases
Full product description
Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC Only. GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108. UPC: 0-03-0766-1480-30-2.
Lots / codes affected
Lot #13L05N, Expiry: 8/15

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.